Cited by 1,381Cell Adhesion Molecules ResearchCellular Mechanics and InteractionsCancer Cells and Metastasis

The DOI matches its Crossref record; 143 of the 143 references it cites were found in a registry or an index.

FAK in cancer: mechanistic findings and clinical applications

Open access

Sulzmaier, Florian J., Jean, Christine, Schlaepfer, David D.·2014·Nature Reviews Cancer

Open this paper in CoChat — free account

Abstract

Focal adhesion kinase (FAK) is a cytoplasmic protein tyrosine kinase that is overexpressed and activated in several advanced-stage solid cancers. FAK promotes tumour progression and metastasis through effects on cancer cells, as well as stromal cells of the tumour microenvironment. The kinase-dependent and kinase-independent functions of FAK control cell movement, invasion, survival, gene expression and cancer stem cell self-renewal. Small molecule FAK inhibitors decrease tumour growth and metastasis in several preclinical models and have initial clinical activity in patients with limited adverse events. In this Review, we discuss FAK signalling effects on both tumour and stromal cell biology that provide rationale and support for future therapeutic opportunities.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nrc3792

Cites

143 of 143 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
The protein kinase complement of the human genome
Manning, G., Whyte, D. B., Martinez, R., Hunter, T., & Sudarsanam, S. (2002) · Science · doi:10.1126/science.1075762 · Cited by 8,145
Integrated genomic analyses of ovarian carcinoma
Perou, C. M. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/hvp3-wg08 · Cited by 7,927
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
Levental, K. R., Yu, H., Kass, L., Lakins, J. N., Egeblad, M., Erler, J. T., Fong, S. F. T., Csiszar, K., Giaccia, A., Weninger, W., et al. (2009) · Cell · doi:10.1016/j.cell.2009.10.027 · Cited by 4,101
Focal adhesion kinase: in command and control of cell motility
Mitra, S. K., Hanson, D. A., & Schlaepfer, D. D. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1549 · Cited by 2,657
Self-citation
Focal adhesion kinase: the first ten years
Parsons, J. T. (2003) · Journal of Cell Science · doi:10.1242/jcs.00373 · Cited by 1,389
The role of focal-adhesion kinase in cancer — a new therapeutic opportunity
McLean, G. W., Carragher, N. O., Avizienyte, E., EVANS, J., Brunton, V. G., & Frame, M. C. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1647 · Cited by 1,049
E-cadherin–integrin crosstalk in cancer invasion and metastasis
Canel, M., Serrels, A., Frame, M. C., & Brunton, V. G. (2013) · Journal of Cell Science · doi:10.1242/jcs.100115 · Cited by 651
Cellular functions of FAK kinases: insight into molecular mechanisms and novel functions
Schaller, M. D. (2010) · Journal of Cell Science · doi:10.1242/jcs.045112 · Cited by 613
Signal transduction by focal adhesion kinase in cancer
Zhao, J., & Guan, J. (2009) · Cancer and Metastasis Reviews · doi:10.1007/s10555-008-9165-4 · Cited by 608

Flagged first, then by citations

Show all 142 references

Sorted by citations

Items 901–1,000 of 1,000

MicroRNA as Key Players in Hepatocellular Carcinoma: Insights into Their Role in Metastasis
Saadh, M. J., Hussain, Q. M., Alazzawi, T. S., Fahdil, A. A., Athab, Z. H., Yarmukhamedov, B., Al-Nuaimi, A. M. A., Alsaikhan, F., & Farhood, B. (2024) · Biochemical Genetics · doi:10.1007/s10528-024-10897-0 · Cited by 8
Targeting Signaling Excitability in Cervical and Pancreatic Cancer Cells Through Combined Inhibition of FAK and PI3K
Chen, C., Wang, S., Yang, J.-M., & Huang, C. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073040 · Cited by 8
The Evolving Understanding of the Molecular and Therapeutic Landscape of Pancreatic Ductal Adenocarcinoma
Parkin, A., Man, J., Chou, A. S. Y., Nagrial, A. M., Samra, J. S., Gill, A. J., Timpson, P., & Pajic, M. (2018) · Diseases · doi:10.3390/diseases6040103 · Cited by 8
Phospho-Aspirin (MDC-22) inhibits pancreatic cancer growth in patient-derived tumor xenografts and KPC mice by targeting EGFR: Enhanced efficacy in combination with irinotecan
Lanzi, C. R., Wei, R., Luo, D., & Mackenzie, G. G. (2021) · Neoplasia · doi:10.1016/j.neo.2021.12.004 · Cited by 8
RIOK3 promotes pancreatic ductal adenocarcinoma cell invasion and metastasis by stabilizing FAK
Xu, M., Fang, L., Guo, X., Qin, H., Sun, R., Ning, Z., & Wang, A. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e10116 · Cited by 8
Complexity of progranulin mechanisms of action in mesothelioma
Ventura, E., Xie, C., Buraschi, S., Belfiore, A., Iozzo, R. V., Giordano, A., & Morrione, A. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02546-4 · Cited by 8
Suppression of the long non-coding RNA LINC01279 triggers autophagy and apoptosis in lung cancer by regulating FAK and SIN3A
Wu, J., Huang, X., Li, X., Zhou, H., Chen, X., Chen, Y., Guo, Y., Huang, J. H., Huang, H., Huang, Z., et al. (2024) · Discover Oncology · doi:10.1007/s12672-023-00855-4 · Cited by 8
Exploring the Therapeutic Potential of Focal Adhesion Kinase Inhibition in Overcoming Chemoresistance in Pancreatic Ductal Adenocarcinoma
Scianò, F., Terrana, F., Pecoraro, C., Parrino, B., Cascioferro, S., Diana, P., Giovannetti, E., & Carbone, D. (2024) · Future Medicinal Chemistry · doi:10.4155/fmc-2023-0234 · Cited by 9
Human fibroblasts display a differential focal adhesion phenotype relative to chimpanzee
Advani, A. S., Chen, A. Y., & Babbitt, C. C. (2016) · Evolution Medicine and Public Health · doi:10.1093/emph/eow010 · Cited by 8
Reversal of the Migratory and Invasive Phenotype of Ras-Transfected Mammary Cells by Photodynamic Therapy Treatment
Calvo, G., Sáenz, D. A., Simian, M., Sampayo, R. G., Mamone, L. A., Vallecorsa, P., Batlle, A. M. D. C., Casas, A. G., & Venosa, G. M. D. (2016) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25657 · Cited by 8
Regulation of FAK Activity by Tetraspan Proteins: Potential Clinical Implications in Cancer
Yu, Q., Mohandessi, S., Gordon, L. K., & Wadehra, M. (2015) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.v20.i5-6.110 · Cited by 8
Leucine-rich glioma inactivated 3: integrative analyses support its prognostic role in glioma
Kwon, N. S., Kim, D., & Yun, H. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s138912 · Cited by 8
Latest perspectives of orally bioavailable 2,4-diarylaminopyrimidine analogues (DAAPalogues) as anaplastic lymphoma kinase inhibitors: discovery and clinical developments
Latif, M., Ashraf, Z., Basit, S., Ghaffar, A., Zafar, M. S., Saeed, A., & Meo, S. A. (2018) · RSC Advances · doi:10.1039/c8ra01934g · Cited by 8
Inhibition of focal adhesion kinase increases myofibril viscosity in cardiac myocytes
Taneja, N., Bersi, M. R., Rasmussen, M. L., Gama, V., Merryman, W. D., & Burnette, D. T. (2020) · Cytoskeleton · doi:10.1002/cm.21632 · Cited by 8
Inhibition of mu-opioid receptor suppresses proliferation of hepatocellular carcinoma cells via CD147-p53-MAPK cascade signaling pathway.
Zhang, J.-J., Song, C., Dai, J., Zhang, X., Lin, P., Li, L., Yang, X.-M., & Chen, Z. (2021) · PubMed Central · Cited by 8
Polymer-based bionanomaterials for biomedical applications
Khan, T. A., & Chauhan, A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823915-5.00006-x · Cited by 8
A genetic variant in PIK3R1 is associated with pancreatic cancer survival in the Chinese population
Zhu, Y., Ke, J., Gong, Y., Yang, Y., Peng, X., Tian, J., Zou, D., Yang, N., Wang, X., Mei, S., et al. (2019) · Cancer Medicine · doi:10.1002/cam4.2228 · Cited by 8
Nuclear Focal Adhesion Kinase Protects against Cisplatin Stress in Ovarian Carcinoma
Zhang, Y., Ojalill, M., Boyer, A. D., Chen, X. L., Tahon, E., Lioux, G. T., Xia, M., Abbas, M., Soylu, H. M., Flieder, D. B., et al. (2024) · Cancer Research Communications · doi:10.1158/2767-9764.crc-24-0382 · Cited by 7
Self-citation
Immobile Integrin Signaling Transit and Relay Nodes Organize Mechanosignaling through Force-Dependent Phosphorylation in Focal Adhesions
Jain, K., Kishan, K., Minhaj, R. F., Kanchanawong, P., Sheetz, M. P., & Changede, R. (2025) · ACS Nano · doi:10.1021/acsnano.4c03214 · Cited by 7
Discovery of potent focal adhesion kinase (FAK) inhibitor A8 with enhanced antitumor activity
Li, Y., He, Y., Zhang, C., Gan, L., & Zhang, H. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.117593 · Cited by 7
CTTN overexpression in HNSCC inhibits Anoikis-apoptosis
Shen, Z.-Z., Xu, Q.-S., Wu, C., Feng, X., & Chen, Q. (2025) · Scientific Reports · doi:10.1038/s41598-025-21891-w · Cited by 7
Predicted miRNAs suppressed cell proliferation and migration via FAK/VASP axis; Systems biology approach
Mohammadi, A., Ghasempour, G., Lotfi, A. S., & Najafi, M. (2022) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2022.100890 · Cited by 7
REPS2 downregulation facilitates FGF-induced adhesion and migration in human lens epithelial cells through FAK/Cdc42 signaling and contributes to posterior capsule opacification
Wen, C., Wang, C., Hu, C., Qi, T., Jing, R., Wang, Y., Zhang, M., Shao, Y., & Pei, C. (2022) · Cellular Signalling · doi:10.1016/j.cellsig.2022.110378 · Cited by 7
CdGAP Is a Talin-Binding Protein and a Target of TGF-β Signaling That Promotes HER2-Positive Breast Cancer Growth and Metastasis
He, Y., Goyette, M.-A., Chapelle, J., Boufaied, N., Rahbani, J. A., Schonewolff, M. F., Danek, E. I., Muller, W. J., Labbé, D. P., Côté, J., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2023.112936 · Cited by 7
On the Value of In Vitro Cell Systems for Mechanobiology from the Perspective of Yes-Associated Protein/Transcriptional Co-Activator with a PDZ-Binding Motif and Focal Adhesion Kinase and Their Involvement in Wound Healing, Cancer, Aging, and Senescence
Steinberg, T., Dieterle, M. P., Ramminger, I., Klein, C., Brossette, J., Husari, A., & Tomakidi, P. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612677 · Cited by 7
MFAP2 upregulation promotes ESCC metastasis via FAK – AKT signaling pathway
Deng, Y., Huang, X., Yang, Y., Zhang, Y. T., Zeng, B., Bao, Y., Cao, L., Wang, X., Ma, L., & Wang, J. (2024) · The FASEB Journal · doi:10.1096/fj.202402411r · Cited by 7
Lung carcinogenesis and fibrosis taken together
Giopanou, I., Arendt, K. A. M., & Stathopoulos, G. T. (2017) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000390 · Cited by 7
Randomized, Open-Label, Crossover Studies Evaluating the Effect of Food and Liquid Formulation on the Pharmacokinetics of the Novel Focal Adhesion Kinase (FAK) Inhibitor BI 853520
Verheijen, R. B., van der Biessen, D. A. J., Hotte, S. J., Siu, L. L., Spreafico, A., de Jonge, M. J. A., Pronk, L. C., Vos, F. D., Schnell, D., Hirte, H. W., et al. (2019) · Targeted Oncology · doi:10.1007/s11523-018-00618-0 · Cited by 7
BACH1: A Potential Predictor of Survival in Early‐Stage Lung Adenocarcinoma
Zhou, J., Liu, Z., Zhang, H., Lei, T., Liu, J., Zhao, Y., Yao, Y., & Song, Q. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/3921095 · Cited by 7
Recent Developments in Medicinal Chemistry and Therapeutic Potential of Anti-Cancer PROTACs-Based Molecules
Khan, M. Z. I., Nazli, A., Pan, Y., & Chen, J. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220803112409 · Cited by 7
SRPX2 Promotes Tumor Proliferation and Migration via the FAK Pathway in Papillary Thyroid Carcinoma
Luo, N., Tan, Y., Deng, H. X., Wu, W., Mei, L., Huang, X., Qin, Y., Zhu, H., & Liu, C. (2022) · Journal of Oncology · doi:10.1155/2022/5821545 · Cited by 7
PYK2 is overexpressed in chronic lymphocytic leukaemia: A potential new therapeutic target
Sbrana, F. V., Fiordi, B., Bordini, J., Belloni, D., Barbaglio, F., Russo, L., Scarfò, L., Ghia, P., & Scielzo, C. (2023) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17688 · Cited by 7
Integrated gene network analysis sheds light on understanding the progression of Osteosarcoma
Dey, H., Vasudevan, K., Doss, C. G. P., Kumar, S. U., Allali, A. E., Alsamman, A. M., & Zayed, H. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1154417 · Cited by 7
Neural Wiskott-Aldrich syndrome protein (N-WASP) promotes distant metastasis in pancreatic ductal adenocarcinoma via activation of LOXL2
Kim, H. S., Yun Sun, L. E. E., Dong, S. M., Kim, H. J., Lee, D. E., Kang, H. W., KIM, M. J., & Park, J. S. (2024) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.32604/or.2024.044029 · Cited by 7
Integrin “endoadhesome” signaling suppresses anoikis
Alanko, J., & Ivaska, J. (2016) · Cell Cycle · doi:10.1080/15384101.2015.1130576 · Cited by 7
Oncogenic effects of urotensin-II in cells lacking tuberous sclerosis complex-2
Goldberg, A. A., Joung, K.-B., Mansuri, A., Kang, Y., Echavarría, R., Nikolajev, L., Sun, Y., Yu, J. J., Laporte, S. A., Schwertani, A. G., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10748 · Cited by 7
Extracellular matrix gene expression profiling using microfluidics for colorectal carcinoma stratification
Hayes, C. J., Dowling, C. M., Dwane, S., McCumiskey, M. E., Tormey, S. M., Merrigan, B. A., Coffey, J. C., Kiely, P. A., & Dalton, T. M. (2016) · Biomicrofluidics · doi:10.1063/1.4966245 · Cited by 7
A combined FAK, c-MET, and MST1R three-protein panel risk-stratifies colorectal cancer patients
Yoon, J., Wang, J. Y., & Roehrl, M. H. A. (2020) · Translational Oncology · doi:10.1016/j.tranon.2020.100836 · Cited by 7
Multi-organ metastasis as destination for breast cancer cells guided by biomechanical architecture: Am J Cancer Res. 2021; 11(6): 2537-2567
Lin, Q. (2025) · American Journal of Cancer Research · doi:10.62347/caul3335 · Cited by 7
EPHB2 expression is associated with intestinal phenotype of gastric cancer and indicates better prognosis by suppressing gastric cancer migration.
Kim, H., Myung, J. K., Paik, S. S., Kim, H., Park, H., Kim, Y. J., Lee, S. B., Kim, H. U., Song, H. J., Jeong, I. H., et al. (2022) · PubMed Central · Cited by 7
Inhibition of focal adhesion kinase/paxillin axis by caffeic acid phenethyl ester restrains aggressive behaviors of head and neck squamous cell carcinoma in vitro
Yu, H., Shin, J., & Cho, S. (2022) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2022.105611 · Cited by 7
PTK2/FAK: a new predictive biomarker for response to radiotherapy in head and neck squamous cell carcinoma
de Ruiter, E. J., & Willems, S. M. (2016) · Annals of Translational Medicine · doi:10.21037/atm.2016.10.19 · Cited by 7
Beta-arrestins operate an on/off control switch for focal adhesion kinase activity
Alexander, R. A., Lot, I., Saha, K., Abadie, G., Lambert, M., Decosta, E., Kobayashi, H., Beautrait, A., Borrull, A., Asnacios, A., et al. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03471-5 · Cited by 7
PDB-1 from Potentilla discolor Bunge suppresses lung cancer cell migration and invasion via FAK/Src and MAPK signaling pathways
Meng, N.-N., Zhang, R., Liu, C., Wang, Q., Wang, X., Guo, X., Wang, P.-P., & Sun, J. (2020) · Medicinal Chemistry Research · doi:10.1007/s00044-020-02527-2 · Cited by 7
Synthesis, characterization and induction of ferroptosis of iridium( iii ) complexes against B16 melanoma cells
Sheng, Z., Liu, Y. F., Xu, L., Yao, X., Chen, J., Liu, Y., & Wang, X. (2025) · Dalton Transactions · doi:10.1039/d5dt00899a · Cited by 6
Focal adhesion kinase inhibition enhances response to checkpoint immunotherapy in hepatocellular carcinoma
Liu, X., Wang, F., Cui, P., Zheng, Z., Zhang, N., & Kong, R. (2025) · Journal of Translational Internal Medicine · doi:10.1515/jtim-2025-0051 · Cited by 6
Impact of mechanical property alterations on cancer cell motility and metastasis
Belousova, P., Kwon, S., Jung, M., & Kim, K. S. (2026) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2026.105165 · Cited by 6
Targeting focal adhesion kinase: from molecular mechanisms to next-generation cancer therapeutics
Chen, J., Bu, Z., & Zhan, Q. (2026) · 中国科学通报：英文版 · doi:10.1016/j.scib.2026.02.048 · Cited by 7
Diversity and Multi-Target Potential of Pyrazole, Imidazole or Triazole Derivatives in Modern Anticancer Therapy
Mysłek, M., Kaczmarek, A., Świątek, P., & Czyżnikowska, Ż. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27104172 · Cited by 6
Positive Phospho-Focal Adhesion Kinase in Gastric Cancer Associates With Poor Prognosis After Curative Resection
Peng, K., Li, S., Li, Q., Zhang, C., Yuan, Y., Liu, M., Zhang, L., Wang, Y., Yu, S., Zhang, H., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.953938 · Cited by 6
FOXN Transcription Factors: Regulation and Significant Role in Cancer
Song, J., Li, L., Fang, Y., Lin, Y., Wu, L., Wan, W., Wei, G., Hua, F., & Ying, J. (2023) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-23-0208 · Cited by 6
Equine β-defensin 1 regulates cytokine expression and phagocytosis in S. aureus-infected mouse monocyte macrophages via the Paxillin-FAK-PI3K pathway
Pei, L., Hou, Y., Feng, Y., Feng, L., Su, H., Zhang, Y., Song, Y., Liu, K., & Cao, G. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110793 · Cited by 6
A selective CB2R agonist (JWH133) protects against pulmonary fibrosis through inhibiting FAK/ERK/S100A4 signaling pathways
Wu, X., Chen, L., Cheng, Y., Zhang, Y., Yang, W., Pan, L., Fu, C., Zhu, H., & Zhang, M. (2023) · BMC Pulmonary Medicine · doi:10.1186/s12890-023-02747-3 · Cited by 6
COL12A1 Promotes Osteosarcoma Progression via the FAK/PI3K/AKT/mTOR Pathway
Zhang, Y.-P., Wang, H.-X., Gao, Z., Xu, L.-Z., & Fu, Y. (2024) · Current Molecular Medicine · doi:10.2174/0115665240322280240903111159 · Cited by 6
Endothelial Cell pY397-FAK Expression Predicts the Risk of Breast Cancer Recurrences after Radiotherapy in the SweBCG91-RT Cohort
Drake, R. J. G., Landén, A. H., Holmberg, E. C., Tullberg, A. S., Killander, F., Niméus, E., Jordan, A., McGuinness, J. R., Karlsson, P., & Hodivala‐Dilke, K. (2025) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-24-2939 · Cited by 6
Self-emulsifying nano-PND oral delivery systems of PND1186: In silico modeling for bioavailability estimation
Vats, M., Rathod, D., Patel, H. J., Richards, T., & Patel, K. (2025) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2025.127161 · Cited by 6
Gravitational and mechanical forces shape mitochondrial translation
Wakigawa, T., Kimura, Y., Mito, M., Tsubaki, T., Lee, M., Nakamura, K., Khan, A. H., Saito, H., Yamamori, T., Yamazaki, T., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-74493-z · Cited by 6
miR-424-5p reduces 5-fluorouracil resistance possibly by inhibiting Src/focal adhesion kinase signalling-mediated epithelial–mesenchymal transition in colon cancer cells
Liu, Y., Wang, G., Li, Y., Zhao, Q., Fan, L., Tan, B., Li, B., Yu, B., & Xi, J. (2021) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgab031 · Cited by 6
Focal Adhesion Kinase Provides a Collateral Vulnerability That Can Be Leveraged to Improve mTORC1 Inhibitor Efficacy
Cuellar-Vite, L., Weber-Bonk, K. L., Abdul‐Karim, F. W., Booth, C. N., & Keri, R. A. (2022) · Cancers · doi:10.3390/cancers14143374 · Cited by 6
Identification of methylation signatures and rules for predicting the severity of SARS-CoV-2 infection with machine learning methods
Liu, Z., Meng, M., Ding, S., Zhou, X., Feng, K., Huang, T., & Cai, Y. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1007295 · Cited by 6
Focal adhesion kinase activation by calcium‐dependent calpain is involved in chronic lymphocytic leukaemia cell aggressiveness
Severin, F., Mouawad, N., Ruggeri, E., Visentin, A., Martinello, L., Pagnin, E., Trimarco, V., Pravato, S., Angotzi, F., Facco, M., et al. (2023) · British Journal of Haematology · doi:10.1111/bjh.18996 · Cited by 6
The Oncolytic Avian Reovirus p17 Protein Inhibits Invadopodia Formation in Murine Melanoma Cancer Cells by Suppressing the FAK/Src Pathway and the Formation of theTKs5/NCK1 Complex
Hsu, C., Li, J., Yang, E.-Y., Liao, T., Wen, H., Tsai, P., Ju, T., Lye, L., Nielsen, B. L., & Liu, H. (2024) · Viruses · doi:10.3390/v16071153 · Cited by 6
New Insights from Drosophila into the Regulation of EGFR Signaling
Harden, N. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7219-7_2 · Cited by 6
SNX-2112, an Hsp90 inhibitor, suppresses cervical cancer cells proliferation, migration, and invasion by inhibiting the Akt/mTOR signaling pathway
Fu, L.-S., Qiu, H., Liu, M., Hu, L., Wang, Y., Zhang, P.-C., Li, M., Wang, Y., & Liu, Z. (2020) · Medicinal Chemistry Research · doi:10.1007/s00044-020-02534-3 · Cited by 6
Identification of a long non-coding RNA regulator of liver carcinoma cell survival
Rybakova, Y., González, J. T., Bogorad, R. L., Chauhan, V. P., Dong, Y. L., Whittaker, C. A., Zatsepin, T. S., Koteliansky, V., & Anderson, D. G. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03453-w · Cited by 6
Expression signature of lncRNA APTR in clinicopathology of breast cancer: Its potential oncogenic function in dysregulation of ErbB signaling pathway
Mansoori, H., Darbeheshti, F., Daraei, A., Mokhtari, M., Tabei, K., Abdollahzadeh, R., Dastsooz, H., Bastami, M., Nariman‐Saleh‐Fam, Z., Salmani, H., et al. (2021) · Gene Reports · doi:10.1016/j.genrep.2021.101116 · Cited by 6
Discovery and Characterisation of Highly Cooperative FAK‐Degrading PROTACs
Law, R. P., Nunes, J., Chung, C., Bantscheff, M., Buda, K., Dai, H., Evans, J. P., Flinders, A., Klimaszewska, D., Lewis, A. J., et al. (2021) · Angewandte Chemie · doi:10.1002/ange.202109237 · Cited by 6
ZINC4085554 inhibits cancer cell adhesion by interfering with the interaction of Akt1 and FAK
More, S. K., Vomhof‐DeKrey, E. E., & Basson, M. D. (2019) · Oncology Letters · doi:10.3892/ol.2019.10192 · Cited by 6
Leucine rich repeat LGI family member 3: Integrative analyses reveal its prognostic association with non‑small cell lung cancer
Kim, D., Kwon, N. S., & Yun, H. (2019) · Oncology Letters · doi:10.3892/ol.2019.10648 · Cited by 6
Overexpressed MAGP1 Is Associated With a Poor Prognosis and Promotes Cell Migration and Invasion in Gastric Cancer
Wu, M., Ding, Y., Jiang, X., Chen, Y., Wu, N., Li, L., Wang, H., Huang, Y., Xu, N., & Teng, L. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2019.01544 · Cited by 6
Identification of novel transcription factor-microRNA-mRNA co-regulatory networks in pulmonary large-cell neuroendocrine carcinoma
Cai, C., Zeng, Q., Zhou, G., & Mu, X. (2021) · Annals of Translational Medicine · doi:10.21037/atm-20-7759 · Cited by 6
Convergent Science Physical Oncology
Nieva, J. J., Bethel, K. J., Baas, C., & Kühn, P. (2015) · Convergent Science Physical Oncology · doi:10.1088/2057-1739/1/1/010201 · Cited by 6
Targeting focal adhesion kinase inhibits cell migration and non-angiogenic vascularization in malignant breast cancer
Masuyama, M., Shimoda, M., Seto, I., Kikumori, K., Abe, K., Masunaga, N., Mishima, C., Tsukabe, M., Yoshinami, T., Sota, Y., et al. (2025) · Breast Cancer · doi:10.1007/s12282-025-01792-6 · Cited by 5
Differential network analysis of ROS1 inhibitors reveals lorlatinib polypharmacology through co-targeting PYK2
Liao, Y., Rix, L. L. R., Li, X., Fang, B., Izumi, V., Welsh, E. A., Monastyrskyi, A., Haura, E. B., Koomen, J. M., Doebele, R. C., et al. (2023) · Cell chemical biology · doi:10.1016/j.chembiol.2023.09.011 · Cited by 5
Proteomic profile of tissue-derived extracellular vesicles from benign odontogenic lesions
Li, S.-R., Li, D.-W., & Man, Q. (2024) · Journal of Stomatology Oral and Maxillofacial Surgery · doi:10.1016/j.jormas.2024.101921 · Cited by 5
Integrated analysis of bulk and single-cell RNA sequencing reveals the impact of nicotinamide and tryptophan metabolism on glioma prognosis and immunotherapy sensitivity
Wang, S., Gao, S., Lin, S., Fang, X., Zhang, H., Qiu, M., Zheng, K., Ji, Y., Xiao, B., & Zhang, X. (2024) · BMC Neurology · doi:10.1186/s12883-024-03924-5 · Cited by 5
Inducible FAK loss but not FAK inhibition in endothelial cells of PYK2-null mice activates p53 tumor suppressor to prevent tumor growth
Chen, X. L., Ojalill, M., Jean, C., Tancioni, I., Jiang, S., Boyer, A. D., Ozmadenci, D., Uryu, S. A., Tarin, D., Schlessinger, J., et al. (2025) · Molecular Biology of the Cell · doi:10.1091/mbc.e24-12-0562 · Cited by 5
Self-citation
Ginkgetin inhibits the proliferation and migration of lung cancer cells via FAK/STAT3/AKT pathway
Sun, L., Chen, W., Yuan, W., Huang, Q., Yang, H., Zhang, W., Tang, J., & Hu, P. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10540-0 · Cited by 5
Pharmacological CLK inhibition disrupts SR protein function and RNA splicing blocking cell growth and migration in TNBC
Liu, N., van der Velde, J. J. S., Ramdjielal, S., Koedoot, E., van Overbeek, N. K., Batenburg, D., Vertegaal, A. C. O., van de Water, B., & Dévédec, S. E. L. (2025) · Breast Cancer Research · doi:10.1186/s13058-025-02091-w · Cited by 5
Phosphoproteomic Analysis Reveals a Different Proteomic Profile in Pediatric Patients With T-Cell Lymphoblastic Lymphoma or T-Cell Acute Lymphoblastic Leukemia
Veltri, G., Lovisa, F., Cortese, G., Pillon, M., Carraro, E., Cesaro, S., Provenzi, M., Buffardi, S., Francescato, S., Biffi, A., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.913487 · Cited by 5
Construction of crizotinib resistant models with CD74-ROS1 D2033N and CD74-ROS1 S1986F point mutations to explore resistance mechanism and treatment strategy
Sun, R., Meng, Y., Xu, R., Li, Y., Xu, X., Li, Z., & Zuo, D. (2022) · Cellular Signalling · doi:10.1016/j.cellsig.2022.110497 · Cited by 5
Identification of PTK2 as an adverse prognostic biomarker in breast cancer by integrated bioinformatics and experimental analyses
Chen, Y., Wang, W., Fang, L., Zhang, Z., & Deng, S. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.984564 · Cited by 5
Targeting FAK/PYK2 with SJP1602 for Anti-Tumor Activity in Triple-Negative Breast Cancer
Jeon, M., Hong, S.-P., Cho, H. J., Park, H., Lee, S., & Ahn, S. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45090446 · Cited by 5
Focal Adhesion Kinase Binds to the HPV E2 Protein to Regulate Initial Replication after Infection
Jose, L., González, J., Kessinger, E., Androphy, E. J., & DeSmet, M. L. (2023) · Pathogens · doi:10.3390/pathogens12101203 · Cited by 5
Cucurbitacin E inhibits the proliferation of glioblastoma cells via FAK/AKT/GSK3β pathway
Chen, W., Liu, F., Lin, X., Li, L., Chen, W., Zhang, T., Liu, Y., Niu, L., Zhang, Y., & Hu, P. (2023) · Oncology Reports · doi:10.3892/or.2023.8658 · Cited by 5
FAK tyrosine 407 organized with integrin αVβ5 in Hs578Ts(i)8 advanced triple-negative breast cancer cells
PAYAN, I., McDonnell, S., de Oliveira, H. T., Steelant, W. F. A., & slambrouck, S. V. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3422 · Cited by 5
Deciphering Biophysical Modulation in Ovarian Cancer Cells
Sarwar, M., Sykes, P. H., Chitcholtan, K., & Evans, J. J. (2021) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-020-00964-9 · Cited by 5
ADP ribosylation factor guanylate kinase 1 promotes the malignant phenotype of gastric cancer by regulating focal adhesion kinase activation
Zhang, S., Luo, Q., Feng, R., Yang, F., Xu, Q., Chen, X., & Yang, S. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119264 · Cited by 5
Targeted protein degraders from an oncologist point of view: The Holy Grail of cancer therapy?
Ambrosini, M., Fucà, G., Duca, M., Damian, S., Santis, F. D., Corti, F., Cresta, S., de Braud, F., & Nicola, M. D. (2021) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2021.103532 · Cited by 5
Differential Chemoproteomics Reveals MARK2/3 as Cell Migration‐Relevant Targets of the ALK Inhibitor Brigatinib
Hu, Q., Liao, Y., Cao, J. A., Fang, B., Yun, S. Y., Kinose, F., Haura, E. B., Lawrence, H. R., Doebele, R. C., Koomen, J. M., et al. (2023) · ChemBioChem · doi:10.1002/cbic.202200766 · Cited by 5
The role of SIPA1 in the development of cancer and metastases (Review)
Liu, C., Jiang, W. G., Hargest, R., & Martin, T. A. (2020) · Molecular and Clinical Oncology · doi:10.3892/mco.2020.2102 · Cited by 6
Synthesis and biological evaluation of novel N-substituted benzamides as anti-migration agents for treatment of osteosarcoma
Chen, X., Wang, G., Alsayed, A. M. M., Du, Z., Liu, L., Ma, Y., Liu, P., Zhang, Q., Chen, X., Chen, W., et al. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113203 · Cited by 5
Pongamol Inhibits Epithelial to Mesenchymal Transition Through Suppression of FAK/Akt-mTOR Signaling
Putri, H. E., Sritularak, B., & Pithi Chanvorachote, B. (2021) · Anticancer Research · doi:10.21873/anticanres.15434 · Cited by 5
3D matrix‐embedding inhibits cycloheximide‐mediated sensitization to TNF‐alpha‐induced apoptosis of human endothelial cells
Saemisch, M., Nickmann, M., Riesinger, L. M., Edelman, E. R., & Methe, H. (2017) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.2609 · Cited by 5
PTK2 promotes uveal melanoma metastasis by activating epithelial‐to‐mesenchymal transition
Luo, P., Duan, J., Chen, Q., Shao, L., Xiao, W., Liu, X., Zhang, G., Tan, X., & Fan, Z. (2023) · MedComm – Oncology · doi:10.1002/mog2.44 · Cited by 4
Application of biomechanics in tumor epigenetic research
Wang, Q., Yin, X., Ding, Y., Zhao, H., & Luo, Y. (2024) · Mechanobiology in Medicine · doi:10.1016/j.mbm.2024.100093 · Cited by 4
Multifunctional hydrogel microspheres regulate the balance of osteoblastic-osteoclastogenesis to treat osteoporotic bone defects by the NFATc1/RANKL/MAPK signaling
Wang, D., Yang, J., Liu, C., Wei, L., Lei, S., Chen, Y., Cheng, P., Huang, Y., Gu, S., Li, H., et al. (2025) · Composites Part B Engineering · doi:10.1016/j.compositesb.2025.112195 · Cited by 4
Exploring Thieno/Furo[2,3-b]pyridines as new scaffolds for potential FAK inhibition: Design, synthesis, biological evaluation and in silico studies
Ismail, A. E., Hassan, N. W., Saudi, M. N. S., Abdel‐Ghany, Y. S., Labib, H. F., El‐Deeb, N. M., & El-Hawash, S. A. (2025) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2025.108392 · Cited by 4
Targeting the hydrophobic pockets of FAK/PYK2 FAT domain: a highly effective inhibitory strategy suppressing tumor growth and eliminating metastasis
Christoforou, M., Charalambous, A., Sfakianakis, D., & Skourides, P. A. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02203-1 · Cited by 4
Molecular hybridization-driven FAK inhibitors: N-2,4-diarylaminopyrimidine-3-sulfamoyl-benzamide derivatives with improved antitumor potency
Gong, L., Liang, Z., Ning, X., He, J., Huang, J., Li, R., Yin, Y., Li, R., & Lin, Z. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.117885 · Cited by 4

Authors: Sulzmaier, F. J., Jean, C., & Schlaepfer, D. D.
Affiliations: University of California San Diego (US)
Corresponding author: Schlaepfer, David D.
ORCID: Sulzmaier, Florian J.
Jean, Christine
Schlaepfer, David D.
Venue: Nature Reviews Cancer
Publisher: Springer Science and Business Media LLC
Published: 2014-08-07
Volume: 14
Issue: 9
Pages: 598-610
ISSN: 1474-175X (ISSN-L)
1474-1768
DOI: 10.1038/nrc3792
PMC: PMC4365862
OpenAlex: W2044423100
Cited by: 1,381
References: 142
Citations by year: 2026: 92 · 2025: 85 · 2024: 131 · 2023: 111 · 2022: 147 · 2021: 154 · 2020: 144 · 2019: 122 · 2018: 105 · 2017: 128 · 2016: 91 · 2015: 63 · 2014: 6
FWCI: 12.73
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Nature reviews. Cancer (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
HAL (submittedVersion)
eScholarship (California Digital Library) (submittedVersion)
Funders: American Heart Association
Verastem Oncology
National Institutes of Health
National Cancer Institute (R01CA102310, CA102310, R01CA180769, CA180769, T32CA121938)
Topics: Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Keywords: focal adhesion kinase, FAK inhibitors, tumor microenvironment, tumor stromal cells, metastasis, tumor progression, cancer stem cells, cell invasion, cell migration, small molecule inhibitors, clinical development
MeSH terms: Animals, Humans, Neoplasm Invasiveness, Neoplasms, Signal Transduction, Stromal Cells, Protein Kinase Inhibitors, Focal Adhesion Kinase 1, Small Molecule Libraries, Molecular Targeted Therapy, Tumor Microenvironment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

FAK in cancer: mechanistic findings and clinical applications

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks